Merck to Limit Drug-Price Increases, Cut Some Prices

Merck & Co. said Thursday it will cut U.S. list prices for several of its drugs including the hepatitis C treatment Zepatier, and the company pledged to limit future net price increases.

from WSJ.com: US Business https://ift.tt/2zTX6YW
via IFTTT